Literature DB >> 25628324

Adenosine-induced tachycardia acceleration: an unusual proarrhythmia.

Vini Singh1, Negar Salehi2, Ranjan Kumar Thakur3.   

Abstract

Adenosine is an effective agent for termination of most re-entrant supraventricular arrhythmias involving the atrioventricular node and often also used as a diagnostic agent for wide QRS tachycardias. Adenosine terminates 90-99% of re-entrant supraventricular tachycardias but it may rarely accelerate tachycardias. Adenosine-induced tachycardia acceleration is a rare phenomenon, as only a handful of cases have been described in the literature. We present a case of a 36-year-old man with a narrow complex, short RP tachycardia at a rate of 165 bpm and an initial blood pressure of 110/78 mm Hg. A bolus of 12 mg of adenosine resulted in slowing of the tachycardia to 150 bpm for 2-3 s, followed by acceleration of the tachycardia to 185 bpm that lasted for approximately 20 s and returned to baseline at 165 bpm. The main mechanism of adenosine-induced acceleration may be the secondary sympathetic stimulation, which may be preceded by transient bradycardia and/or hypotension. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25628324      PMCID: PMC4322274          DOI: 10.1136/bcr-2014-207823

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  Cardiac electrophysiology of adenosine. Basic and clinical concepts.

Authors:  B B Lerman; L Belardinelli
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

2.  Adenosine-induced atrial arrhythmia: a prospective analysis.

Authors:  S A Strickberger; K C Man; E G Daoud; R Goyal; K Brinkman; B P Knight; R Weiss; M Bahu; F Morady
Journal:  Ann Intern Med       Date:  1997-09-15       Impact factor: 25.391

3.  Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.

Authors:  J P DiMarco; W Miles; M Akhtar; S Milstein; A D Sharma; E Platia; B McGovern; M M Scheinman; W C Govier
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

4.  Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.

Authors:  A C Rankin; K G Oldroyd; E Chong; A P Rae; S M Cobbe
Journal:  Br Heart J       Date:  1989-09

5.  Electrophysiologic effects of adenosine in patients with supraventricular tachycardia.

Authors:  K A Glatter; J Cheng; P Dorostkar; G Modin; S Talwar; M Al-Nimri; R J Lee; L A Saxon; M D Lesh; M M Scheinman
Journal:  Circulation       Date:  1999-03-02       Impact factor: 29.690

6.  Adenosine-induced ventricular fibrillation.

Authors:  C P Shah; A K Gupta; R K Thakur; O W Hayes; A Mehrotra; Y Y Lokhandwala
Journal:  Indian Heart J       Date:  2001 Mar-Apr

7.  Adenosine increases sympathetic nerve traffic in humans.

Authors:  I Biaggioni; T J Killian; R Mosqueda-Garcia; R M Robertson; D Robertson
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

Review 8.  Adenosine and the treatment of supraventricular tachycardia.

Authors:  A C Rankin; R Brooks; J N Ruskin; B A McGovern
Journal:  Am J Med       Date:  1992-06       Impact factor: 4.965

9.  Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.

Authors:  J P DiMarco; T D Sellers; R M Berne; G A West; L Belardinelli
Journal:  Circulation       Date:  1983-12       Impact factor: 29.690

Review 10.  Proarrhythmia.

Authors:  P L Friedman; W G Stevenson
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.